Wikipedia

Haileyesus Getahun

Haileyesus (Haile) Getahun is an Ethiopian global health leader, researcher, and advocate. He is currently the chief executive officer of HeDPAC, an organization dedicated to strengthening south-to-south partnerships in health development. [1] Before this role, he served at the WHO headquarters in Geneva from 2003 to 2024, where he led numerous global health initiatives.

Early life and education

edit

Getahun was born and raised in Addis Ababa, Ethiopia. He graduated from Addis Ababa University Medical Faculty as a medical doctor and obtained a Master's in Public Health degree from the Free University of Brussels and a PhD in epidemiology and public health from the Institute of Tropical Medicine Antwerp and Ghent University, Belgium.[2]

Public Health Career in Ethiopia

edit

Getahun began his career as a general practitioner at Estie Health Center in the Amhara region of Ethiopia. He conducted numerous operational and implementation research on neurolathyrism, tuberculosis, and reproductive health while managing the health center and later the zonal health programs department in South Gonder. His rural based research work and publications led to him becoming the first recipient of the Young Public Health Researcher award of Ethiopia in 1999.[2]

Tuberculosis (TB) Research and Programs

edit

Getahun initiated the TB club approach, which empowered communities and improved TB control services in the Estie District and other areas of the Amhara region between 1995 and 1998.[3] This initiative was recognized by the WHO as an initiative to engage communities in TB control activities[4] and replicated in countries such as Nicaragua,[5] India,[6] Mongolia,[7] and Mexico.[8]

Neurolathyrism Research

edit

Getahun was a notable public health researcher in neurolathyrism who investigated and reported the epidemic that occurred in northern Ethiopia in 1997-99.[9] He later conducted a longitudinal ecological study and based on the findings introduced multisectoral measures for the prevention of neurolathyrism involving the health and agriculture sectors.

Reproductive and sexual health research

edit

Getahun served as a youth program manager and principal investigator at the Family Guidance Association of Ethiopia, where he introduced emergency contraception in eight youth centers across the country.

Global Health Career at WHO

edit

Getahun joined the WHO in 2003 to work on HIV related TB. Over his tenure, he expanded his scope to various public health areas until his appointment as CEO of HeDPAC in April 2024.

TB and HIV Work at WHO

edit

Getahun led the development of the first interim TB/HIV policy in 2004,[10] resulting in comprehensive guidelines by 2012.[11] His Lancet publication and work on diagnosing smear-negative TB among HIV-positive individuals had a significant impact on subsequent policy changes and TB care.[12] As the principal investigator of a study published in PLoS Medicine, Getahun's work led to the WHO four-symptom screening for TB, enhancing care for HIV-positive individuals.[13] His publication in the New England Journal of Medicine broadened the focus of TB prevention and led to global policy changes.[14] He collaborated with HIV activist Mark Harrington (HIV/AIDS activist) to introduce and foster patient and community activism in the global TB response,[15] mentoring numerous activists from Africa, Asia and Latin America who became key global advocates. He was awarded the prestigious Union Scientific Prize for his global work on TB and TB/HIV in 2011. [16]

Antimicrobial resistance work at WHO

edit

Getahun became the director of the UN Interagency Coordinating Group (IACG) Secretariat on AMR, established following the 2016 UN General Assembly Political Declaration on AMR.[17] He was the coordinator of the Secretariat and the lead author of the IACG Report, which was submitted to the UN Secretary General.[18] Getahun was also the founding director of the Quadripartite Joint Secretariat on AMR, facilitating inter-agency coordination among the Food and Agriculture Organization of the United Nations (FAO), the United Nations Environment Programme (UNEP),the World Health Organization (WHO), and the World Organisation for Animal Health (WOAH).[19] He led the establishment of the Global Leaders Group on Antimicrobial Resistance in November 2020 and coordinated its work until April 2024.[20] He also coordinated the establishments the AMR Multi-stakeholder Partnership Platform and the AMR Multi-partner Trust Fund. He long advocated for the inclusion of global targets, accountable governance and financing mechanisms for AMR as part of the political declaration of the 2024 United Nations General Assembly High Level Meeting on AMR.[21] He also advocates for antibiotics to be considered as global public good. [22]He was recognized by European Society of Clinical Microbiology and Infectious Diseases as ESCMID Fellow for his work on Antimicrobial Resistance [23]

References

edit
  1. ^ "New South-South health cooperation initiative launched linking Africa and the Caribbean". www.who.int. Retrieved 2024-06-05.
  2. ^ a b Ethiopian News Agency (1999-11-05). "Ethiopia: Dr. Haile-Yesus Getahun Receives Young Public Health Award". All Africa. Retrieved 2024-06-03.
  3. ^ Getahun, H. (November 1998). "Partners against tuberculosis: Ethiopia's "TB clubs"". Africa Health. 21 (1): 20. ISSN 0141-9536. PMID 12294916.
  4. ^ Programme, WHO Global Tuberculosis (2001). ""Community TB Care in Africa" : a collaborative project coordinated by WHO : report on a "lessons learned" meeting in Harare, Zimbabwe, 27-29 September 2000".
  5. ^ Macq, J; Solis, A; Martinez, G; Martiny, P (2004). "Implementing a package of interventions to reduce the negative effects of TB stigma in five municipios of Nicaragua". International Journal of Tuberculosis and Lung Disease. 8: 11S1.
  6. ^ Rangan, S; Gupte, H; Bandiwadekar, A; Girishambe (2003). "Tackling tuberculosis in urban areas: experiences from Mumbai city". Health Administrator (15): 72–79.
  7. ^ He, GX; Zhou, L; Xu, M; Cheng, SM (2005). "Implementing DOTS strategy through tuberculosis clubs". International Journal of Tuberculosis and Lung Disease. 9 ((11S1)): S135–S136.
  8. ^ Alvarez Gordillo, Guadalupe del Carmen; Alvarez Gordillo, Julio Félix; Dorantes Jiménez, José Eugenio (December 2003). "[Educational strategy for improving patient compliance with the tuberculosis treatment regimen in Chiapas, Mexico]". Revista Panamericana de Salud Publica = Pan American Journal of Public Health. 14 (6): 402–408. doi:10.1590/s1020-49892003001100005. ISSN 1020-4989. PMID 14769157.
  9. ^ Getahun, H.; Mekonnen, A.; TekleHaimanot, R.; Lambein, F. (1999-07-24). "Epidemic of neurolathyrism in Ethiopia". Lancet. 354 (9175): 306–307. doi:10.1016/S0140-6736(99)02532-5. ISSN 0140-6736. PMID 10440315.
  10. ^ "Interim Policy on Collaborative TB/HIV Activities". World Health Organization (WHO). 2012.
  11. ^ "WHO Policy on Collaborative TB/HIV Activities". www.who.int. February 27, 2012. Retrieved 2024-06-05.
  12. ^ Getahun, Haileyesus; Harrington, Mark; O'Brien, Rick; Nunn, Paul (2007-06-16). "Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes". Lancet. 369 (9578): 2042–2049. doi:10.1016/S0140-6736(07)60284-0. ISSN 1474-547X. PMID 17574096.
  13. ^ Getahun, Haileyesus; Kittikraisak, Wanitchaya; Heilig, Charles M.; Corbett, Elizabeth L.; Ayles, Helen; Cain, Kevin P.; Grant, Alison D.; Churchyard, Gavin J.; Kimerling, Michael; Shah, Sarita; Lawn, Stephen D.; Wood, Robin; Maartens, Gary; Granich, Reuben; Date, Anand A. (2011-01-18). "Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies". PLOS Medicine. 8 (1): e1000391. doi:10.1371/journal.pmed.1000391. ISSN 1549-1676. PMC 3022524. PMID 21267059.
  14. ^ Getahun, Haileyesus; Matteelli, Alberto; Chaisson, Richard E.; Raviglione, Mario (2015-05-28). Campion, Edward W. (ed.). "Latent Mycobacterium tuberculosis Infection". New England Journal of Medicine. 372 (22): 2127–2135. doi:10.1056/NEJMra1405427. ISSN 0028-4793. PMID 26017823.
  15. ^ Harrington, Mark (2010-05-15). "From HIV to Tuberculosis and Back Again: A Tale of Activism in 2 Pandemics". Clinical Infectious Diseases. 50 (s3): S260–S266. doi:10.1086/651500. ISSN 1058-4838. PMID 20397957.
  16. ^ "The Union Scientific Prize". The Union. 2011.
  17. ^ "Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy - Health Policy Watch". 2018-10-03. Retrieved 2024-06-05.
  18. ^ Jacobs, Andrew (2019-04-29). "U.N. Issues Urgent Warning on the Growing Peril of Drug-Resistant Infections". The New York Times. ISSN 0362-4331. Retrieved 2024-06-05.
  19. ^ "Quadripartite Joint Secretariat on Antimicrobial Resistance". www.qjsamr.org. Retrieved 2024-06-05.
  20. ^ "GLG report: Towards specific commitments and action in the response to antimicrobial resistance". www.amrleaders.org. Retrieved 2024-06-05.
  21. ^ Global Cause (2022). "Seizing the opportunity of UNGA 2024 for bold commitments to AMR". Global Cause. Retrieved 2024-06-05.
  22. ^ Global Cause (2020). "Antibiotics must be accessible to citizens who need them". Global Cause. Retrieved 2024-06-05.
  23. ^ "ESCMID Fellow: Getahun Haileyesus". Retrieved 2024-06-05.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Haileyesus_Getahun&oldid=1255805518"